Answers are grounded in this paper and cite their sources.
The epigenetic landscape, which in part includes DNA methylation, chromatin organization, histone modifications, and noncoding RNA regulation, greatly contributes to the heterogeneity that makes developing effective therapies for lung cancer challenging. This review will provide an overview of the epigenetic alterations that have been implicated in all aspects of cancer pathogenesis and progression as well as summarize clinical applications for targeting epigenetics in the treatment of lung cancer.
No takes yet. Share an insight, caveat, or question.
Chao et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: